Cancer Treatment News and Research

RSS

Study reveals why some women with deadly ovarian cancer respond better to treatment than others

New research is increasing our understanding about why some women with the most lethal form of ovarian cancer respond much better to treatment than others.

21 Jun 2023

$3.3M HHS grant supports UTHealth Houston study on combination treatment strategy for pancreatic cancer

A combination strategy of endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) with chemotherapy for pancreatic cancer will be studied at UTHealth Houston through a $3.3 million grant from the National Cancer Institute by the U.S. Department of Health and Human Services.

20 Jun 2023

New measurement tool helps analyze quality of life after childhood cancer

A new measurement tool helps analyze the survival rate of children with cancer, but also the quality of survival.

20 Jun 2023

Phase I clinical study of TCR NK cell therapy for sarcoma expected to commence later this year

The University of Texas MD Anderson Cancer Center and Replay today announced that the Food & Drug Administration (FDA) has issued a 'safe to proceed' for the Investigational New Drug (IND) application for NY-ESO-1 TCR/IL-15 NK, an engineered T cell receptor natural killer (TCR NK) cell therapy for advanced synovial sarcoma and myxoid/round cell liposarcoma.

20 Jun 2023

Researchers develop a prediction tool for blood cancer therapies

Since its introduction in 2015, a prediction tool developed by the European Society of Medical Oncology has been providing support worldwide in the assessment of the clinical benefits of new cancer therapies.

20 Jun 2023

‘Break the Silence’ campaign urges British fathers to discuss men's health issues with their sons

Men are often reluctant to talk about health matters, and that’s certainly true according to new research by GenesisCare, which reveals that nearly half (49%) of fathers admit they steer clear of talking about men’s health issues with their sons - because they don’t want to scare them (19%).

19 Jun 2023

Combination of two drugs may be more effective in treating resistant breast cancer

Cancer cells are even smarter than scientists previously believed, according to new CU Boulder research.

16 Jun 2023

NCCN guidelines establish an equitable standard of care for cancer outcomes

Today, the National Comprehensive Cancer Network® (NCCN®)-;an alliance of leading cancer centers-;convened a policy summit to examine how geography impacts cancer outcomes.

16 Jun 2023

Older breast cancer survivors show greater epigenetic aging than same-aged people without cancer

In a new multi-center study, researchers from the Medical College of Wisconsin (MCW) joined with leading cancer centers from across the nation to examine whether cancer and its treatments accelerate aging.

14 Jun 2023

OICR funding to help six Ontario-based research teams improve the lives of cancer patients

Funding announced today by the Ontario Institute for Cancer Research (OICR) will help six Ontario-based research teams pursue their ultimate goal of improving the lives of people with cancer.

14 Jun 2023

NCCN introduces new global resource to improve thyroid cancer care in low- and middle-income countries

The National Comprehensive Cancer Network® (NCCN®) is introducing a new global resource to improve thyroid cancer care in low- and middle-income countries at the upcoming World Congress on Thyroid Cancer, in London. During the event, NCCN Senior Vice President and Chief Medical Officer, Wui-Jin Koh, MD, will present on NCCN's ongoing global work to define and advance high-quality, high-value, patient-centered cancer care.

14 Jun 2023

Mark Cuban's Cost Plus Drug Company projects huge savings over Medicare for generic cancer medications

Researchers reveal significant cost savings when generic oncology drugs are purchased through the Mark Cuban Cost Plus Drug Company.

13 Jun 2023

Automated liquid biopsy test predicts early disease progression, survival among patients with metastatic breast cancer

A novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can be used to predict early disease progression and potential survival among patients with metastatic breast cancer in as little as one month after starting treatment, according to a recent study.

13 Jun 2023

Intelligent wound dressing material could bring pain relief to burn patients

One of the challenges in treating burn victims is the frequency of dressing changes, which can be extremely painful. To bring relief to this and other problems, University of Waterloo researchers have created a new type of wound dressing material using advanced polymers.

10 Jun 2023

Global trials could save lives by changing treatment procedure for cancer in the future

Researchers from Edith Cowan University (ECU) are leading ground-breaking global trials which could save lives by changing how we treat cancer in the near future.

9 Jun 2023

Insilico Medicine nominates pan-TEAD inhibitor as a potential solution for drug resistance in solid tumor patients

Insilico Medicine, a generative artificial intelligence (AI)-driven clinical-stage drug discovery company, today announced the nomination of ISM6331, a potential best-in-class pan-TEAD inhibitor, as a preclinical candidate compound (PCC) generated by Chemistry42, its proprietary generative chemistry-driven molecule design engine, targeting the Hippo pathway for the treatment of advanced solid tumors.

8 Jun 2023

Study: Functional limitations among US cancer survivors more than doubled over the past 20 years

The percentage of survivors of cancer reporting functional limitations in the United States has more than doubled over the past 20 years, according to a new study in the journal JAMA Oncology.

7 Jun 2023

Promising targeted therapy offers new hope to certain patients with advanced pancreatic cancer

A promising new targeted cancer therapy will soon be available to certain patients with advanced pancreatic cancer – from the comfort of their home.

7 Jun 2023

New folate-targeting magnetic microrobot system shows great potential in cancer treatment

The limited ability of microrobots to assist drugs in entering cells hinders their therapeutic efficacy. To address this, the cancer-targeting molecule folic acid (FA) was introduced to microrobots to promote drug uptake by cancer cells via receptor-ligand-mediated endocytosis.

6 Jun 2023

New type of wound dressing could enhance the healing process for burn patients

One of the challenges in treating burn victims is the frequency of dressing changes, which can be extremely painful.

6 Jun 2023

Cancer Treatment News and Research

Study reveals why some women with deadly ovarian cancer respond better to treatment than others

$3.3M HHS grant supports UTHealth Houston study on combination treatment strategy for pancreatic cancer

New measurement tool helps analyze quality of life after childhood cancer

Phase I clinical study of TCR NK cell therapy for sarcoma expected to commence later this year

Researchers develop a prediction tool for blood cancer therapies

‘Break the Silence’ campaign urges British fathers to discuss men's health issues with their sons

Combination of two drugs may be more effective in treating resistant breast cancer

NCCN guidelines establish an equitable standard of care for cancer outcomes

Older breast cancer survivors show greater epigenetic aging than same-aged people without cancer

OICR funding to help six Ontario-based research teams improve the lives of cancer patients

NCCN introduces new global resource to improve thyroid cancer care in low- and middle-income countries

Mark Cuban's Cost Plus Drug Company projects huge savings over Medicare for generic cancer medications

Automated liquid biopsy test predicts early disease progression, survival among patients with metastatic breast cancer

Intelligent wound dressing material could bring pain relief to burn patients

Global trials could save lives by changing treatment procedure for cancer in the future

Insilico Medicine nominates pan-TEAD inhibitor as a potential solution for drug resistance in solid tumor patients

Study: Functional limitations among US cancer survivors more than doubled over the past 20 years

Promising targeted therapy offers new hope to certain patients with advanced pancreatic cancer

New folate-targeting magnetic microrobot system shows great potential in cancer treatment

New type of wound dressing could enhance the healing process for burn patients

Cancer Research eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News